National Cancer Center, Division of Cancer Control & Policy, National Cancer Control Institute, Goyang 10408, Korea.
Department of Nursing, College of Nursing, The Catholic University of Korea, Seoul 06591, Korea.
Int J Environ Res Public Health. 2021 Sep 1;18(17):9247. doi: 10.3390/ijerph18179247.
With the increasing burden of cancer worldwide, a need exists to investigate patterns of healthcare utilization and costs. This study aimed to investigate whether the area of residence is associated with the likelihood of a patient receiving treatment at an institution located outside their residing region. This study also analyzed whether medical travel was related to levels of healthcare utilization and costs.
This study used the 2007 to 2015 National Health Insurance (NHI) claims data. The residing area was categorized into capital area, metropolitan cities, and provincial area. Healthcare utilization was measured based on days of care and costs based on direct, covered medical costs. Chi-square test and analysis of variance (ANOVA) was conducted to investigate the general characteristics of the study population. The relationship between the dependent and independent variables were analyzed using the generalized estimating equation (GEE) model.
Of the 64,505 participants included in this study, 19,975 (31.0%) visited medical institutions located outside their residing area. Compared to individuals residing in the capital area, those living in provincial regions (OR 2.202, 95% CI 2.068-2.344) were more likely to visit medical institutions outside their residing area. Healthcare costs were higher in individuals receiving treatment at hospitals located elsewhere (RR 1.054, 95% CI 1.017-1.093).
Cancer patients residing in provincial areas were likely to visit institutions located outside their residing area for treatment. Medical travel was associated with higher levels of spent healthcare costs. Policies should focus on preventing possible related regional cancer disparity and promoting optimal configuration of cancer services.
随着全球癌症负担的增加,需要研究医疗保健利用和成本的模式。本研究旨在调查患者居住地是否与在居住地区以外的机构接受治疗的可能性相关。本研究还分析了医疗旅行是否与医疗保健利用水平和成本有关。
本研究使用了 2007 年至 2015 年的国家健康保险(NHI)理赔数据。居住地区分为首都地区、大都市区和省级地区。医疗保健利用根据护理天数衡量,成本根据直接覆盖的医疗费用计算。采用卡方检验和方差分析(ANOVA)调查研究人群的一般特征。使用广义估计方程(GEE)模型分析因变量和自变量之间的关系。
在纳入本研究的 64505 名参与者中,有 19975 名(31.0%)患者到居住地区以外的医疗机构就诊。与居住在首都地区的个体相比,居住在省级地区的个体更有可能到居住地区以外的医疗机构就诊(OR 2.202,95%CI 2.068-2.344)。在其他地方的医院接受治疗的个体的医疗保健费用更高(RR 1.054,95%CI 1.017-1.093)。
居住在省级地区的癌症患者更有可能到居住地区以外的机构接受治疗。医疗旅行与更高的医疗保健费用支出水平相关。政策应侧重于预防可能出现的相关地区癌症差异,并促进癌症服务的最佳配置。